Apyx Medical Corporation
APYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $12,877 | $11,373 | $9,430 | $14,222 |
| % Growth | 13.2% | 20.6% | -33.7% | – |
| Cost of Goods Sold | $4,580 | $4,290 | $3,765 | $5,258 |
| Gross Profit | $8,297 | $7,083 | $5,665 | $8,964 |
| % Margin | 64.4% | 62.3% | 60.1% | 63% |
| R&D Expenses | $801 | $824 | $804 | $1,117 |
| G&A Expenses | $1,481 | $8,833 | $7,912 | $10,895 |
| SG&A Expenses | $8,328 | $8,833 | $7,912 | $10,895 |
| Sales & Mktg Exp. | $6,847 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,129 | $9,657 | $8,716 | $12,012 |
| Operating Income | -$832 | -$2,574 | -$3,051 | -$3,048 |
| % Margin | -6.5% | -22.6% | -32.4% | -21.4% |
| Other Income/Exp. Net | -$1,045 | -$1,115 | -$1,072 | -$1,522 |
| Pre-Tax Income | -$1,877 | -$3,689 | -$4,123 | -$4,570 |
| Tax Expense | $78 | $49 | $49 | $89 |
| Net Income | -$1,984 | -$3,778 | -$4,150 | -$4,628 |
| % Margin | -15.4% | -33.2% | -44% | -32.5% |
| EPS | 0 | -0.093 | -0.12 | -0.12 |
| % Growth | 100% | 22.7% | 0% | – |
| EPS Diluted | 0 | -0.093 | -0.12 | -0.12 |
| Weighted Avg Shares Out | 40,729 | 40,729 | 35,542 | 38,215 |
| Weighted Avg Shares Out Dil | 40,729 | 40,729 | 35,542 | 38,215 |
| Supplemental Information | – | – | – | – |
| Interest Income | $292 | $278 | $304 | $294 |
| Interest Expense | $1,413 | $1,393 | $1,376 | $1,653 |
| Depreciation & Amortization | $132 | $132 | $138 | $142 |
| EBITDA | -$332 | -$2,164 | -$2,609 | -$2,775 |
| % Margin | -2.6% | -19% | -27.7% | -19.5% |